Home / Companies / Industries / Biotechnology and Drugs / DepoMed, Inc. Overview
DepoMed, Inc. Overview
State:CaliforniaCountry:United States
Industry:Biotechnology and Drugs
Description:
Depomed, Inc. (Depomed) is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. It has developed two products, which have been approved by the Food & Drug Administration (FDA) and are marketed. GLUMETZA is a once-daily treatment for adults with type 2 diabetes that the Company commercialize in the United States with Santarus, Inc. (Santarus). Proquin XR (ciprofloxacin hydrochloride) is a once-daily treatment for uncomplicated urinary tract infections. For the three... (More)
Get Trial Access to OneSource
Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.
Business Information
Executive Profiles
Company Lists
Disclaimer: While the OneSource Subscription Service maintains the freshest, most
accurate data possible, this free site is refreshed on a periodic basis and may
occasionally contain information that is not current. If you would like to alert
us to a change, please email
us, and we will take steps to make sure your update is included as soon
as possible